FDA Advises Against Avastin for Breast Cancer

U.S. Food and Drug Administration officials have recommended revoking approval of the medication Avastin (bevacizumab) for the treatment of breast cancer.

Source: MyBreastCancerNetwork.com – Latest Breast Cancer News

Leave a Reply

Your email address will not be published. Required fields are marked *